13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001789778
Total reported value
$158.8M
$158.8M
9 檔
61.8%
In Q4 2024, Blue Water Life Science Advisors, LP's U.S. equity holdings reached a combined market value of $158.8M, distributed across 9 disclosed stock positions.
In Q4 2024, Blue Water Life Science Advisors, LP displayed an active expansion posture, initiating 1 new positions and adding to 2 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 35.71% | -1.28% | -12.47% | |
| 2 | GH | Guardant Health Inc | Stock-Healthcare | 18.77% | -7.10% | +53.87% | |
| 3 | CDNA | Caredx Inc | Stock-Other | 11.45% | +8.34% | — | |
| 4 | ADPT | Adaptive Biotechnologies | Stock-Other | 11.39% | +2.41% | — | |
| 5 | ✓ | Akoya Biosciences Inc | Stock-Other | 9.53% | — | — | |
| 6 | PSNL | Personalis Inc | Stock-Other | 5.80% | +5.59% | +13.29% | |
| 7 | EXK | Exact Sciences CORP | Stock-Materials | 3.92% | — | -69.11% | |
| 8 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 2.69% | -1.82% | — | |
| 9 | QTRX | Quanterix CORP | Stock-Other | 0.74% | +3.40% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GH | Guardant Health Inc | +9.7% | +53.87% | Add |
| 2 | NTRA | Natera Inc | +3.2% | -12.47% | Trim |
| 3 | TEM | Tempus Ai Inc-cl A | +2.7% | NEW | New buy |
| 4 | ADPT | Adaptive Biotechnologies | +1.7% | — | Unchanged |
| 5 | PSNL | Personalis Inc | +1.1% | +13.29% | Add |
| 6 | QTRX | Quanterix CORP | -0.2% | — | Unchanged |
| 7 | ✓ | Akoya Biosciences Inc | -1.7% | — | Unchanged |
| 8 | CDNA | Caredx Inc | -5.1% | — | Unchanged |
| 9 | EXK | Exact Sciences CORP | -11.4% | -69.11% | Trim |
According to official SEC Form 13F filings, Blue Water Life Science Advisors, LP reported a total U.S. public equity portfolio value of $158.8M across 9 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, GH, CDNA) accounted for 61.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
TEM
市值: $3.0M
Top Position Liquidated / Trimmed
NTRA
前期市值: $37.0M
During Q4 2024, Blue Water Life Science Advisors, LP's top holdings by market value included NTRA (35.7%)、GH (18.8%)、CDNA (11.4%). The largest single position, NTRA, represented 35.7% of total portfolio value.
In Q4 2024, Blue Water Life Science Advisors, LP made 5 total portfolio adjustments, initiating 1 new buys, adding to 2 positions, trimming 2 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.